Maria R Baer

14PUBLICATIONS
121CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 15, 2026
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|Jun 02, 2026
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors.

|May 18, 2026
Glutamine-dependent downregulation of FLT3-ITD is a mechanism of FLT3 inhibitor resistance in FLT3-ITD AML in hypoxia.

|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.

Eric D Eisenmann, Ronan Swords, Ying Huang

|Sep 09, 2024
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.

Chenyu Lin, Anand A Patel, Dezheng Huo

|Jan 29, 2024
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation.

Jonelle K Lee, Aditi Chatterjee, Mario Scarpa

Pageof 3

Frequent Collaborators

3 joint publications

Vu H Duong

3 joint publications

Giovannino Silvestri

3 joint publications

Aditi Chatterjee

2 joint publications

Farhad Ravandi